Phibro Animal Health (PAHC) Total Non-Current Liabilities (2013 - 2026)

Phibro Animal Health's (PAHC) quarterly Total Non-Current Liabilities came in at $1.1 billion in Q1 2026, up 4.13% year-on-year from $1.0 billion in Q1 2025, and up 1.82% quarter-over-quarter from $1.1 billion in Q4 2025.

Phibro Animal Health (PAHC) Total Non-Current Liabilities (2013 - 2026) Analysis & Trends

Phibro Animal Health's Total Non-Current Liabilities history runs 14 years deep, the most recent figure standing at $1.1 billion for Q1 2026.

  • On a quarterly basis, Total Non-Current Liabilities rose 4.13% year-over-year to $1.1 billion in Q1 2026; TTM through Mar 2026 was $1.1 billion, a 4.13% increase from a year earlier, with the FY2025 full-year figure at $995.9 million, up 38.57% from the prior year.
  • Total Non-Current Liabilities rose to $1.1 billion in Q1 2026 per PAHC's latest filing, from $1.1 billion in the prior quarter.
  • Across five years, Total Non-Current Liabilities topped out at $1.1 billion in Q1 2026 and bottomed at $608.8 million in Q2 2022.
  • The 5-year median for Total Non-Current Liabilities is $694.8 million (2023), against an average of $798.6 million.
  • Across the five-year window, Total Non-Current Liabilities retreated 1.89% in 2023 and surged 61.08% in 2025, its largest moves.
  • Year by year, Total Non-Current Liabilities stood at $684.3 million in 2022, then climbed by 1.53% to $694.8 million in 2023, then surged by 47.81% to $1.0 billion in 2024, then increased by 3.48% to $1.1 billion in 2025, then climbed by 1.82% to $1.1 billion in 2026.
  • Per Business Quant, the three latest PAHC Total Non-Current Liabilities figures stand at $1.1 billion (Q1 2026), $1.1 billion (Q4 2025), and $994.7 million (Q3 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Non-Current Liabilities (Qtr)
1 Haleon 87.22 Bn 85.35 Bn - 14.92 Bn
2 Teva Pharmaceutical Industries 39.60 Bn 35.87 Bn 1.97 Bn 18.28 Bn
3 Zoetis 31.46 Bn 29.52 Bn 1.62 Bn 11.64 Bn
4 Takeda Pharmaceutical 26.49 Bn 22.44 Bn 4.39 Bn 33.47 Bn
5 United Therapeutics 23.03 Bn 20.88 Bn 648.10 Mn 599.10 Mn
6 Universe Pharmaceuticals 23.03 Bn -10.56 Bn - -
7 Viatris 20.90 Bn 19.09 Bn 1.16 Bn 20.09 Bn
8 Neurocrine Biosciences 17.50 Bn 16.19 Bn 800.70 Mn 1.24 Bn
9 Elanco Animal Health 12.33 Bn 11.91 Bn 785.00 Mn 6.26 Bn
10 Phibro Animal Health 1.38 Bn 1.30 Bn 125.68 Mn 1.08 Bn

Historic Data

Download Data
DateValue
Mar 31, 2026 1.08 Bn
Dec 31, 2025 1.06 Bn
Sep 30, 2025 994.66 Mn
Jun 30, 2025 995.91 Mn
Mar 31, 2025 1.04 Bn
Dec 31, 2024 1.03 Bn
Sep 30, 2024 701.27 Mn
Jun 30, 2024 718.70 Mn
Mar 31, 2024 645.08 Mn
Dec 31, 2023 694.77 Mn
Sep 30, 2023 685.36 Mn
Jun 30, 2023 682.81 Mn
Mar 31, 2023 631.32 Mn
Dec 31, 2022 684.29 Mn
Sep 30, 2022 679.71 Mn
Jun 30, 2022 608.76 Mn
Mar 31, 2022 643.51 Mn
Dec 31, 2021 553.95 Mn
Sep 30, 2021 546.60 Mn
Jun 30, 2021 546.83 Mn